Ceftriaxone Monotherapy for Severe Bacteremic Infections

Soriano E,J.M. Gatel,José María Aguado,Aguirre Jm,Piedad Arazo,Arribas Jl,Carlos Barros,Cartón Ja,M. Gurgui,Jiménez E,Jiménez de Anta,Josep Mallolas,J.A Maradona,José Mensa,J. Pachón,R. Rodriguez,Antoni Trilla,G. Verger

Ceftriaxone Monotherapy for Severe Bacteremic Infections

1989

Soriano E
J.M. Gatel
José María Aguado
Aguirre Jm
Piedad Arazo
Arribas Jl
Carlos Barros
Cartón Ja
M. Gurgui
Jiménez E
Jiménez de Anta
Josep Mallolas
J.A Maradona
José Mensa
J. Pachón
R. Rodriguez
Antoni Trilla
G. Verger

We tested the efficacy of a single daily dose of ceftriaxone (active ingredient of RocephinTM) for the treatment of severe bacteremic infections in 125 non-neutro-penic adult patients. A si

Keywords:

Haemophilus influenzae
Klebsiella pneumoniae
Immunology
Microbiology
Serratia marcescens
Biology
Staphylococcus aureus
Streptococcus pneumoniae
Escherichia coli
Virology
Bacteremia
Ceftriaxone
Active ingredient
adult patients

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations